manifestation of hamtolyoid neoplasm Flashcards

1
Q

malignancy in nodes :
1. —- tumour
– Carcinoma - Commonest
– Melanoma
– Sarcoma - Rare
– Other rare tumours e.g. Germ cell
2. — malignancy which refers to cancer of any if the formed elements in the blood which can be classified by:
– Lymphomas
* — vs. — Lymphoma
– Leukaemias
* – vs. –
AND
* – vs. –

A

metastatic
haemotologic
Hopkins vs nonhodgkins
acute vs chronic
amyloid vs lymphoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  • malignant haemoposis is monoclonal :
  • Monoclonal cells are defined as a group of cells that are derived from a — ancestral cell by — cellular replication
  • In malignancy these cells divide “ – ” due to cell cycle dysregulation
  • These cells can be said to form a single “ – ”
  • manifestation of lymphoma:
  • Painless lymphadenopathy
  • Abdominal distention, ascites
  • Shortness of breath, pleural effusion
  • Fatigue
  • Fever
  • Night sweats
  • Weight loss
  • Neurological symptoms – CNS disease
A

single
repeated
unchecked
clone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ANN arbor staging:
I – — lymph node region
II – – side of diaphragm
III – – sides of diaphragm
IV – —
A – No – symptoms
B – fever , night sweats weight loss
what tissue might pathologist receive in investigation of an enlarged node;
* Fine Needle Aspirate (FNA)
* Incisional Bx of Node (cores of tissue)
* Excision of Whole Lymph Node

A

single
oe
both
disseminated
systemic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

-lymphoma: malignant proliferation of — which can be — lymphoma and is 85% or — which is 15%
- why classify lymphoma:
* Provide – criteria.
* Allow correct –
* Provide – data
* Allow — of treatment trials
( classification should be reproducible)

A

lymphoid cells
non hodgkin HNL ( b cell 90% m T cell 10%)
hodgkin lymphoma hl ( classical 95% , non classical 5%)
diagnostic
treatment
prognostic
comparison

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

classification by the book:
WHO 2012 – focus on cell of origin
New WHO classification in 2016 (latest update 2024)
* Precursor Lymphoid Neoplasms = – -Grade B and T cell
* Mature Lymphoid Neoplasms = – -grade B and T cell
* Hodgkin Lymphoma
so basically lymphomas clinical behaviour can be — or –

A

high grade
low grade
high or low grade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

diagnostic work for lymphoma - what is CD marker:
* Cell surface markers
– Cells at – stages of differentiation express– which can be used as a – of that cell type.
– CD = —-
– CD molecules can act in a number of different ways – — , — ,— molecules
– CD markers provide targets for — facilitating diagnosis of haematological malignancy as they delineate
benign from malignant phenotypes

A

different
surface proteins
signature
classification determinant
receptors ligands and adhesion molecules
immunophenotyping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  • Neoplasm of — – large
    pleomorphic prominent nucleolus in a halo - Hodgkin cells
  • Reed-Sternberg cell – — Hodgkin
    cell with – appearance
  • Classification:
    1. — Hodgkin
    *Nodular sclerosis
    *Mixed cellularity
    *Lymphocyte rich classical
    *Lymphocyte depleted
    2. — : Nodular
    lymphocyte Predominant
A

B lymphocytes
binucleate
owl eye
classical
non classical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hodgkins Diases :
age: peaks — and –
clinical features:
* — firm node (often cervical)
* Fever
* Night Sweats
* Weight loss
* Pain After Alcohol
* Pruritis
- Hodgkins reed Sternberg cells:
* HRS cells – NB express – and often —
* Rest of node:
— Cells – –
cells, – Cells, —
* Management aims to
strike a balance
between disease control
and minimising early
and late treatment-
related toxicities

A

20 , 30s (60-70%)
enlarged
CD30 , CD15
inflammatory T cells plasma cells and macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

staging of lymphoma :

A
  • CXR
  • CT
  • MRI
  • PET-CT
  • Bone Aspirate
  • Bone Trephine
  • Presence or absence of B symptoms
  • LDH level
  • Performance index
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

non Hopkins lymphoma:
1- b cells : — -Grade
* Burkitt’s Lymphoma
* Diffuse Large B-Cell Lymphoma
* Mantle Cell Lymphoma – more
intermediate
– -Grade
* Follicular
* Marginal Zone Lymphoma
* Lymphoplasmacytic Lymphoma
2- T cells:
Most Behave as High-Grade
* Peripheral T-Cell Lymphoma
(PTCL)
* Angioimmunoblastic T-cell
Lymphoma (AITL)
* Anaplastic Large Cell Lymphoma
(ALK+/ALK-)
* Enteropathy-associated T-cell NHL
(EATL)
* Mycosis Fungoides
* Sezary Syndrome

A

high
low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

b cell lymphoma high grade diffuse —- and —- as well as —

A
  • Diffuse Large Cell B cell lymphoma.
  • Lymphoblastic B cell lymphoma
  • Burkitt’s Lymphoma.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

burritts lymphoma is a type of — lymphoma :
* — grade B cell
* Lymphoblastic
* Requires very aggressive — so
Pathologist must recognise it
* — associated, — translocation
present
* Common in Africa
* PC: Mass in Jaws, GIT, Gonads
* Children & Adolescents
* Very rare in Europe
* Translocation affecting – gene with— of c-Myc function
* Usually t(— ) translocation
* “— ” appearance on histogical section of marrow

A

b
high
chemo
EBV and c-myc
c-myc
deregulation
(8:14)
starry sky

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

 Peripheral T Cell Lymphoma
 Enteropathy associated T Cell Lymphoma
 T Lymphoblastic lymphoma
 T Adult T cell leukaemia/lymphoma
are all examples of –

A

high grade T cell lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

EATL
 Enteropathy Associated T Cell Lymphoma
 This is a complication of — , It occurs in the — and is commoner in those with poor — control.

A

coeliac disease
small bowel
dietry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  • CD 20 and CD 79 B Cell Lymphomas
  • CD 3 T Cell lymphomas
  • BCL2 and CD 10 Follicular lymphoma
  • CD 5 and CD23 Small cell lymphocytic Lymphoma
  • Cyclin D 1 Mantle cell lymphoma
    are all —
A

markers used in low grade lymphoma diagnostic work up ( low grade lymphoma as all are small lymphocyte )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

follicular lymphoma:
* Origin — , —/–
* Contain – follicles
* – grade
* One of the – lymphomas
* Age 50+
* 60% stage – or – at presentation – Why?
* Rarely get cure but indolent disease
-Translocation chromosome – and other chromosome, usually –
Over expression –
(anti apoptotic gene).

A

follicle, centrocyte/centroblast
neoplastic
low
commonest
iii and iv
14
14:18
BCL2

17
Q

BCL2 is – in follicles in follicular lymphoma but – in benign follicular hyperplasia which is an important marker
- follicular lymphoma are – but — and 70% – year survival and 20% transform to —

A

positive
negative
indolent but progressive
5 years
high grade

18
Q

mantle cell lymphoma :
- diffuse replacemnt of node by malignant mantle cells
* – grade B cell
* < 5% of lymphomas
* Peak 60-70
* Often – stage at presentation
* — positive
* t(—) translocation
* 20-40% – year survival (Despite being low grade)
- morphology: usually small cells w — appearance , blasted variant has more – course, occurs in adults more in — and median survival is —
- immuo: has CD20+ CD79a

A

low
high
cyclin d1
11:14
5
centrocyte like
aggressive
males
3-4 years

19
Q

interpreting g a pathology report:

A
  • Check it is the correct report for your patient – name,
    DOB, patient unique identifier – know what you are
    actually looking at
  • Check pathology site and biopsy type – was the correct
    site biopsied?
  • Did you provide the correct information to the surgeon,
    radiologist/pathologist?
  • Discuss at Lymphoma MDT – clinical correlation, newly
    diagnosed vs. relapsed
  • Read the report end to end
    – Know terminology – malignant, clonal, CD markers, grade,
    prognostic features e.g. MIB index – what does this mean?
    – Do you understand the diagnosis?
    BREAKING BAD NEWS:
  • As a doctor you will be required to interpret the report of cancer biopsies
    and then break the news of cancer to patients and their families
  • Read the report alone first without the patient present – be sure you know
    the meaning of the report and the MDT outcome
  • Take into account cultural, ethical, special needs of the patient
  • Relate the results in plain language that the patient can understand – do not
    use medical jargon – important to actually verbalise the word “cancer” and
    not leave the patient guessing
  • Give the patient time to digest the information you have told them – this may
    require several visits
  • Give time for the patient to ask any questions
  • Arrange follow up – this is not a once off meeting, the patient needs a plan
    and a place to go with queries